Interventions for preventing osteoporosis in women on heparin therapy during pregnancy-Reference-Cited by-同舟云学术

Interventions for preventing osteoporosis in women on heparin therapy during pregnancy

Published:2015-09-18 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Abdollahi Mohammad¹,Nikfar Shekoufeh²,Hosseini-Tabatabaei Azadeh³,Rezaie Ali⁴

Affiliation:

1. Tehran University of Medical Sciences; Faculty of Pharmacy, and Pharmaceutical Sciences Research Centre; Keshavarz Bulvd. Tehran Tehran Iran 1417614411

2. Tehran University of Medical Sciences; Food and Drug Laboratory Research Centre, Deputy for Food and Drug Affairs, Iranian Ministry of Health and Medical Education; and Department of Pharmacoeconomics and Pharmaceutical Administration, Faculty of Pharmacy; Tehran Iran

3. University of British Columbia; Department of Surgery; Burn and Wound Healing Research Lab, Jack Bell Research Centre Rm 344A, 2660 Oak St. Vancouver BC Canada V6H 3Z6

4. Cedars-Sinai Medical Center; Department of Medicine; Los Angeles California USA 90048

Publisher

Wiley

Subject

Pharmacology (medical)

Reference37 articles.

1. Risk factors for venous thromboembolism following prolonged air travel. Coach class thrombosis;Arfvidsson;Hematology/Oncology Clinics of North America,2000

2. Bone density changes in pregnant women treated with heparin: a prospective, longitudinal study;Backos;Human Reproduction,1999

3. The novel anticoagulants: entering a new era;Bounameaux;Swiss Medical Weekly,2009

4. Prospective observational study of bone mineral density during pregnancy: low molecular weight heparin versus control;Carlin;Human Reproduction,2004

5. Prospective evaluation of bone density in pregnant women receiving the low molecular weight heparin enoxaparin sodium;Casele;Journal of Maternal-Fetal Medicine,2000